Rapid development of broadly influenza neutralizing antibodies through redundant mutations

The main pathway of somatic mutations leading to the generation of high affinity broadly neutralizing antibodies against the influenza haemagglutinin stem is defined. Anti-influenza antibody creation By reconstructing the genealogy trees of several influenza-specific human B cell clones, Antonio Lan...

Full description

Saved in:
Bibliographic Details
Published inNature (London) Vol. 516; no. 7531; pp. 418 - 422
Main Authors Pappas, Leontios, Foglierini, Mathilde, Piccoli, Luca, Kallewaard, Nicole L., Turrini, Filippo, Silacci, Chiara, Fernandez-Rodriguez, Blanca, Agatic, Gloria, Giacchetto-Sasselli, Isabella, Pellicciotta, Gabriele, Sallusto, Federica, Zhu, Qing, Vicenzi, Elisa, Corti, Davide, Lanzavecchia, Antonio
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 18.12.2014
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN0028-0836
1476-4687
1476-4687
DOI10.1038/nature13764

Cover

Loading…
Abstract The main pathway of somatic mutations leading to the generation of high affinity broadly neutralizing antibodies against the influenza haemagglutinin stem is defined. Anti-influenza antibody creation By reconstructing the genealogy trees of several influenza-specific human B cell clones, Antonio Lanzavecchia and colleagues have identified a main pathway leading to high affinity broadly neutralizing antibodies against the stem regions of viral haemagglutinin molecules. In most instances a single point mutation confers high affinity binding and neutralization activity, with subsequent mutations conferring increased breadth of the response. The neutralizing antibody response to influenza virus is dominated by antibodies that bind to the globular head of haemagglutinin, which undergoes a continuous antigenic drift, necessitating the re-formulation of influenza vaccines on an annual basis. Recently, several laboratories have described a new class of rare influenza-neutralizing antibodies that target a conserved site in the haemagglutinin stem 1 , 2 , 3 , 4 , 5 , 6 . Most of these antibodies use the heavy-chain variable region VH1-69 gene, and structural data demonstrate that they bind to the haemagglutinin stem through conserved heavy-chain complementarity determining region (HCDR) residues. However, the VH1-69 antibodies are highly mutated and are produced by some but not all individuals 6 , 7 , suggesting that several somatic mutations may be required for their development 8 , 9 . To address this, here we characterize 197 anti-stem antibodies from a single donor, reconstruct the developmental pathways of several VH1-69 clones and identify two key elements that are required for the initial development of most VH1-69 antibodies: a polymorphic germline-encoded phenylalanine at position 54 and a conserved tyrosine at position 98 in HCDR3. Strikingly, in most cases a single proline to alanine mutation at position 52a in HCDR2 is sufficient to confer high affinity binding to the selecting H1 antigen, consistent with rapid affinity maturation. Surprisingly, additional favourable mutations continue to accumulate, increasing the breadth of reactivity and making both the initial mutations and phenylalanine at position 54 functionally redundant. These results define VH1-69 allele polymorphism, rearrangement of the VDJ gene segments and single somatic mutations as the three requirements for generating broadly neutralizing VH1-69 antibodies and reveal an unexpected redundancy in the affinity maturation process.
AbstractList The neutralizing antibody response to influenza virus is dominated by antibodies that bind to the globular head of haemagglutinin, which undergoes a continuous antigenic drift, necessitating the re-formulation of influenza vaccines on an annual basis. Recently, several laboratories have described a new class of rare influenza-neutralizing antibodies that target a conserved site in the haemagglutinin stem. Most of these antibodies use the heavy-chain variable region VH1-69 gene, and structural data demonstrate that they bind to the haemagglutinin stem through conserved heavy-chain complementarity determining region (HCDR) residues. However, the VH1-69 antibodies are highly mutated and are produced by some but not all individuals, suggesting that several somatic mutations may be required for their development. To address this, here we characterize 197 anti-stem antibodies from a single donor, reconstruct the developmental pathways of several VH1-69 clones and identify two key elements that are required for the initial development of most VH1-69 antibodies: a polymorphic germline-encoded phenylalanine at position 54 and a conserved tyrosine at position 98 in HCDR3. Strikingly, in most cases a single proline to alanine mutation at position 52a in HCDR2 is sufficient to confer high affinity binding to the selecting H1 antigen, consistent with rapid affinity maturation. Surprisingly, additional favourable mutations continue to accumulate, increasing the breadth of reactivity and making both the initial mutations and phenylalanine at position 54 functionally redundant. These results define VH1-69 allele polymorphism, rearrangement of the VDJ gene segments and single somatic mutations as the three requirements for generating broadly neutralizing VH1-69 antibodies and reveal an unexpected redundancy in the affinity maturation process.The neutralizing antibody response to influenza virus is dominated by antibodies that bind to the globular head of haemagglutinin, which undergoes a continuous antigenic drift, necessitating the re-formulation of influenza vaccines on an annual basis. Recently, several laboratories have described a new class of rare influenza-neutralizing antibodies that target a conserved site in the haemagglutinin stem. Most of these antibodies use the heavy-chain variable region VH1-69 gene, and structural data demonstrate that they bind to the haemagglutinin stem through conserved heavy-chain complementarity determining region (HCDR) residues. However, the VH1-69 antibodies are highly mutated and are produced by some but not all individuals, suggesting that several somatic mutations may be required for their development. To address this, here we characterize 197 anti-stem antibodies from a single donor, reconstruct the developmental pathways of several VH1-69 clones and identify two key elements that are required for the initial development of most VH1-69 antibodies: a polymorphic germline-encoded phenylalanine at position 54 and a conserved tyrosine at position 98 in HCDR3. Strikingly, in most cases a single proline to alanine mutation at position 52a in HCDR2 is sufficient to confer high affinity binding to the selecting H1 antigen, consistent with rapid affinity maturation. Surprisingly, additional favourable mutations continue to accumulate, increasing the breadth of reactivity and making both the initial mutations and phenylalanine at position 54 functionally redundant. These results define VH1-69 allele polymorphism, rearrangement of the VDJ gene segments and single somatic mutations as the three requirements for generating broadly neutralizing VH1-69 antibodies and reveal an unexpected redundancy in the affinity maturation process.
The main pathway of somatic mutations leading to the generation of high affinity broadly neutralizing antibodies against the influenza haemagglutinin stem is defined. Anti-influenza antibody creation By reconstructing the genealogy trees of several influenza-specific human B cell clones, Antonio Lanzavecchia and colleagues have identified a main pathway leading to high affinity broadly neutralizing antibodies against the stem regions of viral haemagglutinin molecules. In most instances a single point mutation confers high affinity binding and neutralization activity, with subsequent mutations conferring increased breadth of the response. The neutralizing antibody response to influenza virus is dominated by antibodies that bind to the globular head of haemagglutinin, which undergoes a continuous antigenic drift, necessitating the re-formulation of influenza vaccines on an annual basis. Recently, several laboratories have described a new class of rare influenza-neutralizing antibodies that target a conserved site in the haemagglutinin stem 1 , 2 , 3 , 4 , 5 , 6 . Most of these antibodies use the heavy-chain variable region VH1-69 gene, and structural data demonstrate that they bind to the haemagglutinin stem through conserved heavy-chain complementarity determining region (HCDR) residues. However, the VH1-69 antibodies are highly mutated and are produced by some but not all individuals 6 , 7 , suggesting that several somatic mutations may be required for their development 8 , 9 . To address this, here we characterize 197 anti-stem antibodies from a single donor, reconstruct the developmental pathways of several VH1-69 clones and identify two key elements that are required for the initial development of most VH1-69 antibodies: a polymorphic germline-encoded phenylalanine at position 54 and a conserved tyrosine at position 98 in HCDR3. Strikingly, in most cases a single proline to alanine mutation at position 52a in HCDR2 is sufficient to confer high affinity binding to the selecting H1 antigen, consistent with rapid affinity maturation. Surprisingly, additional favourable mutations continue to accumulate, increasing the breadth of reactivity and making both the initial mutations and phenylalanine at position 54 functionally redundant. These results define VH1-69 allele polymorphism, rearrangement of the VDJ gene segments and single somatic mutations as the three requirements for generating broadly neutralizing VH1-69 antibodies and reveal an unexpected redundancy in the affinity maturation process.
The neutralizing antibody response to influenza virus is dominated by antibodies that bind to the globular head of haemagglutinin, which undergoes a continuous antigenic drift, necessitating the re-formulation of influenza vaccines on an annual basis. Recently, several laboratories have described a new class of rare influenza-neutralizing antibodies that target a conserved site in the haemagglutinin stem. Most of these antibodies use the heavy-chain variable region VH1-69 gene, and structural data demonstrate that they bind to the haemagglutinin stem through conserved heavy-chain complementarity determining region (HCDR) residues. However, the VH1-69 antibodies are highly mutated and are produced by some but not all individuals, suggesting that several somatic mutations may be required for their development. To address this, here we characterize 197 anti-stem antibodies from a single donor, reconstruct the developmental pathways of several VH1-69 clones and identify two key elements that are required for the initial development of most VH1-69 antibodies: a polymorphic germline-encoded phenylalanine at position 54 and a conserved tyrosine at position 98 in HCDR3. Strikingly, in most cases a single proline to alanine mutation at position 52a in HCDR2 is sufficient to confer high affinity binding to the selecting H1 antigen, consistent with rapid affinity maturation. Surprisingly, additional favourable mutations continue to accumulate, increasing the breadth of reactivity and making both the initial mutations and phenylalanine at position 54 functionally redundant. These results define VH1-69 allele polymorphism, rearrangement of the VDJ gene segments and single somatic mutations as the three requirements for generating broadly neutralizing VH1-69 antibodies and reveal an unexpected redundancy in the affinity maturation process.
Audience Academic
Author Lanzavecchia, Antonio
Pappas, Leontios
Pellicciotta, Gabriele
Kallewaard, Nicole L.
Giacchetto-Sasselli, Isabella
Silacci, Chiara
Zhu, Qing
Piccoli, Luca
Sallusto, Federica
Vicenzi, Elisa
Corti, Davide
Turrini, Filippo
Fernandez-Rodriguez, Blanca
Foglierini, Mathilde
Agatic, Gloria
Author_xml – sequence: 1
  givenname: Leontios
  surname: Pappas
  fullname: Pappas, Leontios
  organization: Insitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland
– sequence: 2
  givenname: Mathilde
  surname: Foglierini
  fullname: Foglierini, Mathilde
  organization: Insitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland
– sequence: 3
  givenname: Luca
  surname: Piccoli
  fullname: Piccoli, Luca
  organization: Insitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland
– sequence: 4
  givenname: Nicole L.
  surname: Kallewaard
  fullname: Kallewaard, Nicole L.
  organization: Department of Infectious Diseases and Vaccines MedImmune LLC, One MedImmune Way
– sequence: 5
  givenname: Filippo
  surname: Turrini
  fullname: Turrini, Filippo
  organization: Viral Pathogens and Biosafety Unit, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milan, Italy
– sequence: 6
  givenname: Chiara
  surname: Silacci
  fullname: Silacci, Chiara
  organization: Insitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland
– sequence: 7
  givenname: Blanca
  surname: Fernandez-Rodriguez
  fullname: Fernandez-Rodriguez, Blanca
  organization: Insitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland
– sequence: 8
  givenname: Gloria
  surname: Agatic
  fullname: Agatic, Gloria
  organization: Humabs BioMed SA, Via Mirasole 1, 6500 Bellinzona, Switzerland
– sequence: 9
  givenname: Isabella
  surname: Giacchetto-Sasselli
  fullname: Giacchetto-Sasselli, Isabella
  organization: Insitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland
– sequence: 10
  givenname: Gabriele
  surname: Pellicciotta
  fullname: Pellicciotta, Gabriele
  organization: Unit of Preventive Medicine, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milan, Italy
– sequence: 11
  givenname: Federica
  surname: Sallusto
  fullname: Sallusto, Federica
  organization: Insitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland
– sequence: 12
  givenname: Qing
  surname: Zhu
  fullname: Zhu, Qing
  organization: Department of Infectious Diseases and Vaccines MedImmune LLC, One MedImmune Way
– sequence: 13
  givenname: Elisa
  surname: Vicenzi
  fullname: Vicenzi, Elisa
  organization: Viral Pathogens and Biosafety Unit, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milan, Italy
– sequence: 14
  givenname: Davide
  surname: Corti
  fullname: Corti, Davide
  organization: Insitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland, Humabs BioMed SA, Via Mirasole 1, 6500 Bellinzona, Switzerland
– sequence: 15
  givenname: Antonio
  surname: Lanzavecchia
  fullname: Lanzavecchia, Antonio
  email: lanzavecchia@irb.usi.ch
  organization: Insitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland, Insitute for Microbiology, ETH Zurich, Wolfgang-Pauli-Strasse 10, 8093 Zurich, Switzerland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25296253$$D View this record in MEDLINE/PubMed
BookMark eNp10ktv1DAQAGALFdFt4cQdRXABQYqdOI5zrCoelSohFbhwiRx7nLpK7K0fiPbX49UW2K2CfLBkfzPyeOYIHVhnAaHnBJ8QXPP3VsTkgdQto4_QitCWlZTx9gCtMK54iXnNDtFRCNcY44a09Ak6rJqqY1VTr9CPS7E2qlDwEya3nsHGwuli8E6o6bYwVk8J7J0oLKToxWTujB0LYaMZnDIQinjlXRqvCg8qWZUvijlFEY2z4Sl6rMUU4Nn9foy-f_zw7exzefHl0_nZ6UUpG85iKQgB3ahBk440FWVKEwpqqAglmMtaaslZJwfBeKOlrJjCWLC2oTVALkiL-hi93uZde3eTIMR-NkHCNAkLLoWesLqjHa9wnemrB_TaJW_z67KimLUt68g_NYoJ-vwHLpcuN0n7U8pqThijG1UuqBEs5H_KHdImH-_5lwters1Nv4tOFlBeCmYjF7O-2QvIJsKvOIoUQn_-9XLfvrivPg0zqH7tzSz8bf9nGjJ4uwXSuxA86L-E4H4za_3OrGVNHmhptq3PbzbTf2LebWNCzmxH8DsNWOC_ATQ65J4
CODEN NATUAS
CitedBy_id crossref_primary_10_1093_intimm_dxz049
crossref_primary_10_15252_embj_201899243
crossref_primary_10_1126_scitranslmed_ads8214
crossref_primary_10_3389_fimmu_2024_1471396
crossref_primary_10_1186_s12879_018_3517_7
crossref_primary_10_1371_journal_ppat_1011554
crossref_primary_10_1038_s41586_020_2456_9
crossref_primary_10_1128_mBio_01144_21
crossref_primary_10_3389_fimmu_2018_03004
crossref_primary_10_1038_s41564_021_00972_2
crossref_primary_10_1111_imm_13012
crossref_primary_10_1016_j_it_2017_04_003
crossref_primary_10_1016_j_it_2015_04_005
crossref_primary_10_1016_j_coviro_2022_101207
crossref_primary_10_1016_j_coi_2018_04_009
crossref_primary_10_1007_s00251_024_01363_7
crossref_primary_10_3389_fimmu_2019_02365
crossref_primary_10_1101_cshperspect_a029413
crossref_primary_10_1016_j_chom_2020_05_010
crossref_primary_10_3390_vaccines8030424
crossref_primary_10_1126_science_aad5224
crossref_primary_10_3389_fimmu_2018_02149
crossref_primary_10_1016_j_celrep_2023_112370
crossref_primary_10_1016_j_jim_2020_112752
crossref_primary_10_1016_j_coviro_2019_02_004
crossref_primary_10_1172_JCI99597
crossref_primary_10_1016_j_celrep_2017_11_056
crossref_primary_10_1371_journal_pbio_1002321
crossref_primary_10_1146_annurev_animal_021419_083813
crossref_primary_10_1016_j_immuni_2019_09_016
crossref_primary_10_1016_j_coviro_2016_03_002
crossref_primary_10_3389_fimmu_2021_730471
crossref_primary_10_3390_vaccines11101577
crossref_primary_10_2217_fvl_2016_0045
crossref_primary_10_1007_s00401_017_1705_y
crossref_primary_10_1016_j_immuni_2023_06_019
crossref_primary_10_3390_microorganisms8111745
crossref_primary_10_1016_j_celrep_2017_08_084
crossref_primary_10_1126_sciimmunol_aan2676
crossref_primary_10_1016_j_celrep_2019_03_020
crossref_primary_10_1126_sciimmunol_aap8029
crossref_primary_10_1016_j_biotechadv_2023_108143
crossref_primary_10_3389_fimmu_2022_951385
crossref_primary_10_1038_ncomms13577
crossref_primary_10_3389_fimmu_2021_662909
crossref_primary_10_1093_abt_tbab008
crossref_primary_10_1038_nm_3963
crossref_primary_10_1093_intimm_dxaa028
crossref_primary_10_3389_fimmu_2017_01407
crossref_primary_10_1016_j_cell_2015_06_057
crossref_primary_10_3390_vaccines9020125
crossref_primary_10_1016_j_jconrel_2019_08_039
crossref_primary_10_1038_s41467_017_00736_9
crossref_primary_10_1371_journal_pone_0225063
crossref_primary_10_1016_j_micinf_2020_06_003
crossref_primary_10_1084_jem_20240668
crossref_primary_10_1172_JCI178880
crossref_primary_10_1111_imr_12395
crossref_primary_10_1371_journal_ppat_1011514
crossref_primary_10_1038_s41591_021_01636_8
crossref_primary_10_2139_ssrn_3272234
crossref_primary_10_1084_jem_20200206
crossref_primary_10_1016_j_chom_2019_01_010
crossref_primary_10_1172_jci_insight_129035
crossref_primary_10_3389_fimmu_2021_708882
crossref_primary_10_1073_pnas_1500788112
crossref_primary_10_1038_s41467_020_14579_4
crossref_primary_10_1016_j_cell_2017_04_024
crossref_primary_10_7554_eLife_83628
crossref_primary_10_1016_j_tim_2016_09_003
crossref_primary_10_1107_S2053230X14027599
crossref_primary_10_1016_j_cell_2015_10_004
crossref_primary_10_1038_s41467_025_56496_4
crossref_primary_10_1038_s41467_022_29950_w
crossref_primary_10_1093_nar_gkac995
crossref_primary_10_1016_j_immuni_2021_02_013
crossref_primary_10_3389_fimmu_2018_00600
crossref_primary_10_1016_j_molimm_2018_02_013
crossref_primary_10_1038_s41467_023_39690_0
crossref_primary_10_1016_j_celrep_2021_109604
crossref_primary_10_1016_j_it_2022_11_001
crossref_primary_10_1016_j_immuni_2022_07_006
crossref_primary_10_3389_fimmu_2019_00829
crossref_primary_10_1016_j_cels_2020_09_005
crossref_primary_10_1089_aid_2022_0104
crossref_primary_10_15252_emmm_201808879
crossref_primary_10_1098_rstb_2014_0236
crossref_primary_10_1016_j_celrep_2019_12_063
crossref_primary_10_1016_j_immuni_2024_07_022
crossref_primary_10_1038_srep33843
crossref_primary_10_3390_cells10081864
crossref_primary_10_1146_annurev_immunol_041015_055325
crossref_primary_10_1128_JVI_01850_17
crossref_primary_10_1126_science_aap9608
crossref_primary_10_1016_j_chom_2017_07_013
crossref_primary_10_1021_acssuschemeng_2c01760
crossref_primary_10_1080_22221751_2022_2140611
crossref_primary_10_1016_j_immuni_2023_11_004
crossref_primary_10_1038_nature16450
crossref_primary_10_1002_anbr_202100122
crossref_primary_10_1016_j_immuni_2020_10_005
crossref_primary_10_1016_j_cell_2016_06_043
crossref_primary_10_1038_s41467_024_51770_3
crossref_primary_10_1073_pnas_1614940113
crossref_primary_10_1038_ncomms13376
crossref_primary_10_1371_journal_ppat_1011603
crossref_primary_10_1016_j_coviro_2015_03_019
crossref_primary_10_1111_imr_12509
crossref_primary_10_1146_annurev_immunol_102819_023144
crossref_primary_10_1146_annurev_med_091014_090749
crossref_primary_10_1016_j_csbj_2019_03_009
crossref_primary_10_3389_fimmu_2015_00531
crossref_primary_10_1016_j_chom_2016_05_014
crossref_primary_10_1016_j_coi_2018_05_010
crossref_primary_10_1038_nri_2016_67
crossref_primary_10_1038_s41541_017_0019_3
crossref_primary_10_1016_j_coi_2016_12_004
crossref_primary_10_1016_j_celrep_2024_114990
crossref_primary_10_3390_v12091053
crossref_primary_10_1016_j_chom_2018_10_009
crossref_primary_10_1016_j_immuni_2021_12_003
crossref_primary_10_1016_j_coi_2017_03_002
crossref_primary_10_1021_acssensors_9b00968
crossref_primary_10_1128_jvi_01223_24
crossref_primary_10_1038_s41435_021_00145_5
crossref_primary_10_1089_vim_2017_0025
crossref_primary_10_1111_all_13394
crossref_primary_10_1038_ncomms9223
crossref_primary_10_1038_ncomms8375
crossref_primary_10_1038_s41467_019_11821_6
crossref_primary_10_1016_j_coi_2016_06_001
crossref_primary_10_1016_j_immuni_2015_11_007
crossref_primary_10_1016_j_vaccine_2017_10_093
crossref_primary_10_1016_j_celrep_2023_113194
crossref_primary_10_1016_j_antiviral_2023_105591
crossref_primary_10_1016_j_immuni_2021_08_013
crossref_primary_10_1016_j_celrep_2022_110763
crossref_primary_10_1080_22221751_2021_1925594
crossref_primary_10_1016_j_vaccine_2017_08_053
crossref_primary_10_1016_j_chom_2018_09_010
crossref_primary_10_1016_j_celrep_2021_108950
crossref_primary_10_3390_vaccines8030382
crossref_primary_10_1038_s41564_023_01413_y
crossref_primary_10_1016_j_coisb_2019_10_004
crossref_primary_10_1128_JVI_00093_16
crossref_primary_10_3389_fimmu_2023_1201136
crossref_primary_10_1126_scitranslmed_ade4976
crossref_primary_10_1093_infdis_jiy696
crossref_primary_10_3390_vaccines9111352
crossref_primary_10_1016_j_coviro_2017_03_002
crossref_primary_10_1084_jem_20231314
crossref_primary_10_3389_fimmu_2018_02451
crossref_primary_10_1038_s41541_021_00342_3
crossref_primary_10_1038_s41392_021_00858_z
crossref_primary_10_4049_jimmunol_1701728
crossref_primary_10_3389_fimmu_2016_00619
crossref_primary_10_1002_art_40590
crossref_primary_10_1016_j_immuni_2016_10_027
crossref_primary_10_1016_j_coviro_2015_04_002
crossref_primary_10_3389_fimmu_2017_00143
crossref_primary_10_1016_j_antiviral_2019_104564
crossref_primary_10_1126_science_aaf8505
crossref_primary_10_1371_journal_pone_0183315
crossref_primary_10_1016_j_isci_2024_109716
crossref_primary_10_1128_CVI_00544_16
crossref_primary_10_1016_j_celrep_2020_108430
crossref_primary_10_1038_srep15053
crossref_primary_10_1038_nri_2017_78
crossref_primary_10_1093_protein_gzz013
crossref_primary_10_1016_j_chom_2017_08_011
crossref_primary_10_3390_vaccines10081227
crossref_primary_10_1080_22221751_2019_1701953
crossref_primary_10_1016_j_celrep_2020_108088
crossref_primary_10_3390_vaccines7020053
crossref_primary_10_1038_ncomms15371
crossref_primary_10_1038_s41590_023_01559_1
crossref_primary_10_1038_srep37229
crossref_primary_10_1038_s41467_021_24090_z
crossref_primary_10_3389_fimmu_2020_01011
crossref_primary_10_1111_imr_12821
crossref_primary_10_1038_s41541_024_00811_5
crossref_primary_10_1038_srep35173
crossref_primary_10_1084_jem_20191792
crossref_primary_10_1002_eji_202451045
crossref_primary_10_1016_j_celrep_2019_11_084
crossref_primary_10_1016_j_it_2020_03_005
crossref_primary_10_1093_infdis_jiab064
crossref_primary_10_1371_journal_pcbi_1007731
crossref_primary_10_1038_ncomms12780
crossref_primary_10_1016_j_immuni_2016_04_016
crossref_primary_10_1186_s12936_020_03548_3
crossref_primary_10_1007_s13238_015_0160_6
crossref_primary_10_1038_s41418_019_0318_5
crossref_primary_10_1084_jem_20200513
crossref_primary_10_1016_j_jmb_2023_168344
crossref_primary_10_1016_j_smim_2015_03_008
crossref_primary_10_1038_nm_4513
crossref_primary_10_1111_imr_12808
crossref_primary_10_1016_j_immuni_2019_09_001
crossref_primary_10_1038_srep32340
crossref_primary_10_1128_JVI_00880_16
crossref_primary_10_1016_j_cell_2015_12_022
crossref_primary_10_1016_j_immuni_2018_08_025
crossref_primary_10_1016_j_immuni_2017_12_009
crossref_primary_10_1073_pnas_1901340116
crossref_primary_10_1016_j_coisb_2018_11_002
crossref_primary_10_7554_eLife_81743
crossref_primary_10_1016_j_celrep_2020_108065
crossref_primary_10_3390_v13071392
crossref_primary_10_1080_22221751_2023_2245931
crossref_primary_10_1172_JCI148763
crossref_primary_10_1038_s41541_017_0020_x
crossref_primary_10_1084_jem_20142284
crossref_primary_10_1016_j_jaut_2024_103241
crossref_primary_10_1038_srep20842
crossref_primary_10_1111_jth_13956
crossref_primary_10_4049_jimmunol_1402835
crossref_primary_10_1016_j_celrep_2023_113410
crossref_primary_10_1038_s41467_021_21968_w
crossref_primary_10_1038_s42003_017_0006_2
crossref_primary_10_1172_jci_insight_135449
crossref_primary_10_7554_eLife_71393
crossref_primary_10_1093_protein_gzaa028
crossref_primary_10_1016_j_cell_2016_05_073
crossref_primary_10_3390_v13060965
crossref_primary_10_3389_fimmu_2018_01315
crossref_primary_10_3390_vaccines8010013
crossref_primary_10_1038_nprot_2016_009
crossref_primary_10_1016_j_coi_2015_02_011
crossref_primary_10_1016_j_immuni_2016_09_001
crossref_primary_10_1016_j_molimm_2021_08_017
crossref_primary_10_1126_scitranslmed_aad0522
crossref_primary_10_1038_s41590_022_01230_1
crossref_primary_10_1038_srep12411
crossref_primary_10_1073_pnas_2412787122
crossref_primary_10_1126_sciadv_aav1882
crossref_primary_10_1093_brain_awz106
crossref_primary_10_1016_j_coi_2018_03_020
crossref_primary_10_1080_19420862_2016_1170263
crossref_primary_10_3389_fimmu_2017_01563
crossref_primary_10_1016_j_celrep_2018_07_093
Cites_doi 10.1126/science.1171491
10.1016/S1074-7613(00)80580-4
10.1073/pnas.1218256109
10.1371/journal.ppat.1004103
10.1016/S0042-6822(02)00035-1
10.1093/intimm/dxt030
10.1073/pnas.92.5.1254
10.1016/j.jim.2007.09.017
10.1084/jem.20101352
10.1016/j.cell.2013.03.018
10.1093/rheumatology/41.4.401
10.1038/ni.1814
10.1038/nature12442
10.1111/j.1750-2659.2007.00016.x
10.1038/nature12053
10.1128/CVI.00735-12
10.1093/nar/gkt382
10.1073/pnas.81.10.3180
10.1038/nsmb.1566
10.1016/j.molimm.2008.05.022
10.4049/jimmunol.1000928
10.1371/journal.pone.0022365
10.1097/01.aids.0000432474.76873.5f
10.1038/nri3516
10.1038/354389a0
10.1073/pnas.1301810110
10.1126/science.1205669
10.1172/JCI41902
10.1038/nature11371
10.1371/journal.pone.0003942
10.1016/j.vaccine.2009.10.066
10.1093/nar/gkn316
10.1038/nm1080
10.1172/JCI116468
10.1126/science.1222908
10.1146/annurev-immunol-020711-075032
10.1172/JCI118644
10.1126/science.1201730
10.1093/nar/gkq313
ContentType Journal Article
Copyright Springer Nature Limited 2014
COPYRIGHT 2014 Nature Publishing Group
Copyright Nature Publishing Group Dec 18-Dec 25, 2014
Copyright_xml – notice: Springer Nature Limited 2014
– notice: COPYRIGHT 2014 Nature Publishing Group
– notice: Copyright Nature Publishing Group Dec 18-Dec 25, 2014
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QG
7QL
7QP
7QR
7RV
7SN
7SS
7ST
7T5
7TG
7TK
7TM
7TO
7U9
7X2
7X7
7XB
88A
88E
88G
88I
8AF
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
8G5
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BEC
BENPR
BGLVJ
BHPHI
BKSAR
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M2M
M2O
M2P
M7N
M7P
M7S
MBDVC
NAPCQ
P5Z
P62
P64
PATMY
PCBAR
PDBOC
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
PTHSS
PYCSY
Q9U
R05
RC3
S0X
SOI
7X8
DOI 10.1038/nature13764
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Environment Abstracts
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
Science Database (Alumni Edition)
STEM Database
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
Materials Science & Engineering Collection (subscription)
ProQuest Central (Alumni Edition)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection (subscription)
ProQuest Central Essentials
Biological Science Collection
eLibrary
ProQuest Central - New (Subscription)
Technology Collection
Natural Science Collection
Earth, Atmospheric & Aquatic Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
ProQuest Biological Science Collection
Agricultural Science Database
Health & Medical Collection (Alumni Edition)
Medical Database
Psychology Database
Research Library (subscription)
Science Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database (subscription)
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest advanced technologies & aerospace journals
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database (subscripiton)
Earth, Atmospheric & Aquatic Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
Engineering collection
Environmental Science Collection
ProQuest Central Basic
University of Michigan
Genetics Abstracts
SIRS Editorial
Environment Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
ProQuest One Psychology
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
elibrary
ProQuest AP Science
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Earth, Atmospheric & Aquatic Science Database
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
University of Michigan
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
SIRS Editorial
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Earth, Atmospheric & Aquatic Science Collection
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Research Library
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Central Basic
ProQuest Science Journals
ProQuest Nursing & Allied Health Source
ProQuest Psychology Journals (Alumni)
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
ProQuest Psychology Journals
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
Environment Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Agricultural Science Database
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Physics
EISSN 1476-4687
EndPage 422
ExternalDocumentID 3538303011
A463816641
25296253
10_1038_nature13764
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: U19 AI-057266
GroupedDBID ---
--Z
-DZ
-ET
-~X
.55
.CO
.XZ
00M
07C
0R~
0WA
123
186
1OL
1VR
29M
2KS
2XV
39C
3V.
4.4
41X
53G
5RE
6TJ
70F
7RV
7X2
7X7
7XC
85S
88A
88E
88I
8AF
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
8G5
8R4
8R5
8WZ
97F
97L
A6W
A7Z
A8Z
AAEEF
AAHBH
AAHTB
AAIKC
AAKAB
AAKAS
AAMNW
AASDW
AAYEP
AAYZH
AAZLF
ABAWZ
ABDBF
ABDQB
ABFSI
ABIVO
ABJCF
ABJNI
ABLJU
ABOCM
ABPEJ
ABPPZ
ABUWG
ABWJO
ABZEH
ACBEA
ACBWK
ACGFO
ACGFS
ACGOD
ACIWK
ACKOT
ACMJI
ACNCT
ACPRK
ACUHS
ACWUS
ADBBV
ADFRT
ADUKH
ADYSU
ADZCM
AENEX
AEUYN
AFFNX
AFKRA
AFLOW
AFRAH
AFSHS
AGAYW
AGHSJ
AGHTU
AGNAY
AGSOS
AHMBA
AHSBF
AIDAL
AIDUJ
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
APEBS
ARAPS
ARMCB
ARTTT
ASPBG
ATCPS
ATWCN
AVWKF
AXYYD
AZFZN
AZQEC
B0M
BBNVY
BCU
BDKGC
BEC
BENPR
BGLVJ
BHPHI
BIN
BKEYQ
BKKNO
BKSAR
BLC
BPHCQ
BVXVI
CCPQU
CJ0
CS3
D1I
D1J
D1K
DO4
DU5
DWQXO
E.-
E.L
EAD
EAP
EAS
EAZ
EBC
EBD
EBO
EBS
ECC
EE.
EJD
EMB
EMF
EMH
EMK
EMOBN
EPL
EPS
ESE
ESN
ESX
EX3
EXGXG
F5P
FEDTE
FQGFK
FSGXE
FYUFA
GNUQQ
GUQSH
HCIFZ
HMCUK
HVGLF
HZ~
I-F
IAO
ICQ
IEA
IEP
IGS
IH2
IHR
INH
INR
IOF
IPY
ISR
ITC
K6-
KB.
KOO
L6V
L7B
LK5
LK8
LSO
M0K
M0L
M1P
M2M
M2O
M2P
M7P
M7R
M7S
N9A
NAPCQ
NEJ
NEPJS
O9-
OBC
OES
OHH
OMK
OVD
P-O
P2P
P62
PATMY
PCBAR
PDBOC
PKN
PM3
PQQKQ
PROAC
PSQYO
PSYQQ
PTHSS
PYCSY
Q2X
R05
RND
RNS
RNT
RNTTT
RXW
S0X
SC5
SHXYY
SIXXV
SJFOW
SJN
SNYQT
SOJ
SV3
TAE
TAOOD
TBHMF
TDRGL
TEORI
TH9
TN5
TSG
TUS
TWZ
U5U
UIG
UKHRP
UKR
UMD
UQL
VQA
VVN
WH7
WOW
X7M
XIH
XKW
XZL
Y6R
YAE
YCJ
YFH
YIF
YIN
YNT
YOC
YQT
YR2
YR5
YXB
YZZ
Z5M
ZCA
ZE2
ZKB
~02
~7V
~88
~8M
~KM
AARCD
AAYXX
ABFSG
ACMFV
ACSTC
ADGHP
ADXHL
AETEA
AFANA
ALPWD
ATHPR
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
AEIIB
PMFND
7QG
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7TG
7TK
7TM
7TO
7U9
7XB
8FD
8FK
C1K
FR3
H94
K9.
KL.
M7N
MBDVC
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
RC3
SOI
7X8
ID FETCH-LOGICAL-c586t-a11ef5dbf1915246df14edb214108c3cfc869cba685fcc26d00a67543ee000fa3
IEDL.DBID 8C1
ISSN 0028-0836
1476-4687
IngestDate Fri Jul 11 04:27:42 EDT 2025
Fri Jul 25 09:03:25 EDT 2025
Tue Jun 17 21:18:30 EDT 2025
Thu Jun 12 23:37:43 EDT 2025
Tue Jun 10 15:33:04 EDT 2025
Tue Jun 10 20:28:29 EDT 2025
Fri Jun 27 03:57:58 EDT 2025
Wed Feb 19 01:55:39 EST 2025
Tue Jul 01 03:21:24 EDT 2025
Thu Apr 24 23:10:58 EDT 2025
Fri Feb 21 02:37:48 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 7531
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c586t-a11ef5dbf1915246df14edb214108c3cfc869cba685fcc26d00a67543ee000fa3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 25296253
PQID 1640677691
PQPubID 40569
PageCount 5
ParticipantIDs proquest_miscellaneous_1639498203
proquest_journals_1640677691
gale_infotracmisc_A463816641
gale_infotracgeneralonefile_A463816641
gale_infotraccpiq_463816641
gale_infotracacademiconefile_A463816641
gale_incontextgauss_ISR_A463816641
pubmed_primary_25296253
crossref_primary_10_1038_nature13764
crossref_citationtrail_10_1038_nature13764
springer_journals_10_1038_nature13764
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-12-18
PublicationDateYYYYMMDD 2014-12-18
PublicationDate_xml – month: 12
  year: 2014
  text: 2014-12-18
  day: 18
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationSubtitle International weekly journal of science
PublicationTitle Nature (London)
PublicationTitleAbbrev Nature
PublicationTitleAlternate Nature
PublicationYear 2014
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Brochet, Lefranc, Giudicelli (CR37) 2008; 36
Sangster (CR15) 2013; 20
Arnaout (CR38) 2011; 6
Throsby (CR5) 2008; 3
Victora, Nussenzweig (CR23) 2012; 30
Lingwood (CR9) 2012; 489
Poulsen, Jensen, Haurum, Andersen (CR21) 2011; 187
Hassantoufighi (CR33) 2010; 28
Tiller (CR32) 2008; 329
Ye, Ma, Madden, Ostell (CR36) 2013; 41
Jacob, Kelsoe, Rajewsky, Weiss (CR10) 1991; 354
Foote, Eisen (CR20) 1995; 92
Sasso, Willems van Dijk, Bull, Milner (CR39) 1993; 91
Wrammert (CR6) 2011; 208
Kwong, Mascola, Nabel (CR22) 2013; 13
Jin (CR28) 2003; 306
Klein (CR17) 2013; 153
McKean (CR11) 1984; 81
Vencovský (CR14) 2002; 41
Avnir (CR16) 2014; 10
Batista, Neuberger (CR19) 1998; 8
Corti (CR7) 2010; 120
Traggiai (CR31) 2004; 10
Kaji (CR26) 2013; 25
Corti (CR4) 2011; 333
Goujon (CR34) 2010; 38
Dogan (CR24) 2009; 10
Dreyfus (CR3) 2012; 337
Wang (CR8) 2013; 110
Sasso, Johnson, Kipps (CR13) 1996; 97
Schmidt (CR18) 2013; 110
Sui (CR1) 2009; 16
Liao (CR12) 2013; 496
Abhinandan, Martin (CR35) 2008; 45
Corti (CR27) 2013; 501
Ekiert (CR2) 2009; 324
Pape, Taylor, Maul, Gearhart, Jenkins (CR25) 2011; 331
Temperton (CR29) 2007; 1
Ghezzi (CR30) 2013; 27
PD Kwong (BFnature13764_CR22) 2013; 13
E Traggiai (BFnature13764_CR31) 2004; 10
M Throsby (BFnature13764_CR5) 2008; 3
KA Pape (BFnature13764_CR25) 2011; 331
AG Schmidt (BFnature13764_CR18) 2013; 110
J Ye (BFnature13764_CR36) 2013; 41
D Corti (BFnature13764_CR27) 2013; 501
KR Abhinandan (BFnature13764_CR35) 2008; 45
T Kaji (BFnature13764_CR26) 2013; 25
F Wang (BFnature13764_CR8) 2013; 110
EH Sasso (BFnature13764_CR39) 1993; 91
EH Sasso (BFnature13764_CR13) 1996; 97
D McKean (BFnature13764_CR11) 1984; 81
S Ghezzi (BFnature13764_CR30) 2013; 27
NJ Temperton (BFnature13764_CR29) 2007; 1
X Brochet (BFnature13764_CR37) 2008; 36
R Arnaout (BFnature13764_CR38) 2011; 6
MY Sangster (BFnature13764_CR15) 2013; 20
DC Ekiert (BFnature13764_CR2) 2009; 324
C Dreyfus (BFnature13764_CR3) 2012; 337
H Jin (BFnature13764_CR28) 2003; 306
J Wrammert (BFnature13764_CR6) 2011; 208
D Corti (BFnature13764_CR4) 2011; 333
GD Victora (BFnature13764_CR23) 2012; 30
F Batista (BFnature13764_CR19) 1998; 8
Y Avnir (BFnature13764_CR16) 2014; 10
D Corti (BFnature13764_CR7) 2010; 120
F Klein (BFnature13764_CR17) 2013; 153
D Lingwood (BFnature13764_CR9) 2012; 489
A Hassantoufighi (BFnature13764_CR33) 2010; 28
M Goujon (BFnature13764_CR34) 2010; 38
J Vencovský (BFnature13764_CR14) 2002; 41
J Foote (BFnature13764_CR20) 1995; 92
J Sui (BFnature13764_CR1) 2009; 16
I Dogan (BFnature13764_CR24) 2009; 10
H-X Liao (BFnature13764_CR12) 2013; 496
TR Poulsen (BFnature13764_CR21) 2011; 187
T Tiller (BFnature13764_CR32) 2008; 329
J Jacob (BFnature13764_CR10) 1991; 354
8099917 - J Clin Invest. 1993 Jun;91(6):2358-67
21310965 - Science. 2011 Mar 4;331(6021):1203-7
23175789 - Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):264-9
1956400 - Nature. 1991 Dec 5;354(6352):389-92
11961170 - Rheumatology (Oxford). 2002 Apr;41(4):401-10
17996249 - J Immunol Methods. 2008 Jan 1;329(1-2):112-24
19855380 - Nat Immunol. 2009 Dec;10(12):1292-9
19453415 - Influenza Other Respir Viruses. 2007 May;1(3):105-12
24788925 - PLoS Pathog. 2014 May 01;10(5):e1004103
23576673 - Clin Vaccine Immunol. 2013 Jun;20(6):867-76
22224772 - Annu Rev Immunol. 2012;30:429-57
19251591 - Science. 2009 Apr 10;324(5924):246-51
22932267 - Nature. 2012 Sep 27;489(7417):566-70
12620793 - Virology. 2003 Feb 1;306(1):18-24
23969737 - Nat Rev Immunol. 2013 Sep;13(9):693-701
21220454 - J Exp Med. 2011 Jan 17;208(1):181-93
15247913 - Nat Med. 2004 Aug;10(8):871-5
23955151 - Nature. 2013 Sep 19;501(7467):439-43
23921607 - AIDS. 2013 Sep 24;27(15):2335-44
23540694 - Cell. 2013 Mar 28;153(1):126-38
23552890 - Nature. 2013 Apr 25;496(7446):469-76
18614234 - Mol Immunol. 2008 Aug;45(14):3832-9
21798894 - Science. 2011 Aug 12;333(6044):850-6
19234466 - Nat Struct Mol Biol. 2009 Mar;16(3):265-73
22878502 - Science. 2012 Sep 14;337(6100):1343-8
21930965 - J Immunol. 2011 Oct 15;187(8):4229-35
20389023 - J Clin Invest. 2010 May;120(5):1663-73
23671333 - Nucleic Acids Res. 2013 Jul;41(Web Server issue):W34-40
24021876 - Int Immunol. 2013 Dec;25(12):683-95
23440204 - Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4261-6
21829618 - PLoS One. 2011;6(8):e22365
8621797 - J Clin Invest. 1996 May 1;97(9):2074-80
20439314 - Nucleic Acids Res. 2010 Jul;38(Web Server issue):W695-9
19079604 - PLoS One. 2008;3(12):e3942
6203114 - Proc Natl Acad Sci U S A. 1984 May;81(10):3180-4
18503082 - Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W503-8
9655489 - Immunity. 1998 Jun;8(6):751-9
7877964 - Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1254-6
19887135 - Vaccine. 2010 Jan 8;28(3):790-7
References_xml – volume: 324
  start-page: 246
  year: 2009
  end-page: 251
  ident: CR2
  article-title: Antibody recognition of a highly conserved influenza virus epitope
  publication-title: Science
  doi: 10.1126/science.1171491
– volume: 8
  start-page: 751
  year: 1998
  end-page: 759
  ident: CR19
  article-title: Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate
  publication-title: Immunity
  doi: 10.1016/S1074-7613(00)80580-4
– volume: 110
  start-page: 264
  year: 2013
  end-page: 269
  ident: CR18
  article-title: Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1218256109
– volume: 10
  start-page: e1004103
  year: 2014
  ident: CR16
  article-title: Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1004103
– volume: 306
  start-page: 18
  year: 2003
  end-page: 24
  ident: CR28
  article-title: Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60
  publication-title: Virology
  doi: 10.1016/S0042-6822(02)00035-1
– volume: 25
  start-page: 683
  year: 2013
  end-page: 695
  ident: CR26
  article-title: Both mutated and unmutated memory B cells accumulate mutations in the course of the secondary response and develop a new antibody repertoire optimally adapted to the secondary stimulus
  publication-title: Int. Immunol.
  doi: 10.1093/intimm/dxt030
– volume: 92
  start-page: 1254
  year: 1995
  end-page: 1256
  ident: CR20
  article-title: Kinetic and affinity limits on antibodies produced during immune responses
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.92.5.1254
– volume: 329
  start-page: 112
  year: 2008
  end-page: 124
  ident: CR32
  article-title: Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning
  publication-title: J. Immunol. Methods
  doi: 10.1016/j.jim.2007.09.017
– volume: 208
  start-page: 181
  year: 2011
  end-page: 193
  ident: CR6
  article-title: Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20101352
– volume: 153
  start-page: 126
  year: 2013
  end-page: 138
  ident: CR17
  article-title: Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization
  publication-title: Cell
  doi: 10.1016/j.cell.2013.03.018
– volume: 41
  start-page: 401
  year: 2002
  end-page: 410
  ident: CR14
  article-title: Polymorphism in the immunoglobulin VH gene V1-69 affects susceptibility to rheumatoid arthritis in subjects lacking the HLA-DRB1 shared epitope
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/41.4.401
– volume: 10
  start-page: 1292
  year: 2009
  end-page: 1299
  ident: CR24
  article-title: Multiple layers of B cell memory with different effector functions
  publication-title: Nature Immunol.
  doi: 10.1038/ni.1814
– volume: 501
  start-page: 439
  year: 2013
  end-page: 443
  ident: CR27
  article-title: Cross-neutralization of four paramyxoviruses by a human monoclonal antibody
  publication-title: Nature
  doi: 10.1038/nature12442
– volume: 1
  start-page: 105
  year: 2007
  end-page: 112
  ident: CR29
  article-title: A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies
  publication-title: Influenza Other Respi. Viruses
  doi: 10.1111/j.1750-2659.2007.00016.x
– volume: 496
  start-page: 469
  year: 2013
  end-page: 476
  ident: CR12
  article-title: Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
  publication-title: Nature
  doi: 10.1038/nature12053
– volume: 20
  start-page: 867
  year: 2013
  end-page: 876
  ident: CR15
  article-title: B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination
  publication-title: Clin. Vaccine Immunol.
  doi: 10.1128/CVI.00735-12
– volume: 41
  start-page: W34
  year: 2013
  end-page: W40
  ident: CR36
  article-title: IgBLAST: an immunoglobulin variable domain sequence analysis tool
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkt382
– volume: 81
  start-page: 3180
  year: 1984
  end-page: 3184
  ident: CR11
  article-title: Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.81.10.3180
– volume: 16
  start-page: 265
  year: 2009
  end-page: 273
  ident: CR1
  article-title: Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
  publication-title: Nature Struct. Mol. Biol.
  doi: 10.1038/nsmb.1566
– volume: 45
  start-page: 3832
  year: 2008
  end-page: 3839
  ident: CR35
  article-title: Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2008.05.022
– volume: 187
  start-page: 4229
  year: 2011
  end-page: 4235
  ident: CR21
  article-title: Limits for antibody affinity maturation and repertoire diversification in hypervaccinated humans
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1000928
– volume: 6
  start-page: e22365
  year: 2011
  ident: CR38
  article-title: High-resolution description of antibody heavy-chain repertoires in humans
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0022365
– volume: 27
  start-page: 2335
  year: 2013
  end-page: 2344
  ident: CR30
  article-title: Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 disease
  publication-title: AIDS
  doi: 10.1097/01.aids.0000432474.76873.5f
– volume: 13
  start-page: 693
  year: 2013
  end-page: 701
  ident: CR22
  article-title: Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning
  publication-title: Nature Rev. Immunol.
  doi: 10.1038/nri3516
– volume: 354
  start-page: 389
  year: 1991
  end-page: 392
  ident: CR10
  article-title: Intraclonal generation of antibody mutants in germinal centres
  publication-title: Nature
  doi: 10.1038/354389a0
– volume: 110
  start-page: 4261
  year: 2013
  end-page: 4266
  ident: CR8
  article-title: Somatic hypermutation maintains antibody thermodynamic stability during affinity maturation
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1301810110
– volume: 333
  start-page: 850
  year: 2011
  end-page: 856
  ident: CR4
  article-title: A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins
  publication-title: Science
  doi: 10.1126/science.1205669
– volume: 120
  start-page: 1663
  year: 2010
  end-page: 1673
  ident: CR7
  article-title: Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI41902
– volume: 489
  start-page: 566
  year: 2012
  end-page: 570
  ident: CR9
  article-title: Structural and genetic basis for development of broadly neutralizing influenza antibodies
  publication-title: Nature
  doi: 10.1038/nature11371
– volume: 3
  start-page: e3942
  year: 2008
  ident: CR5
  article-title: Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0003942
– volume: 28
  start-page: 790
  year: 2010
  end-page: 797
  ident: CR33
  article-title: A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.10.066
– volume: 36
  start-page: W503
  year: 2008
  end-page: W508
  ident: CR37
  article-title: IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkn316
– volume: 10
  start-page: 871
  year: 2004
  end-page: 875
  ident: CR31
  article-title: An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
  publication-title: Nature Med.
  doi: 10.1038/nm1080
– volume: 91
  start-page: 2358
  year: 1993
  end-page: 2367
  ident: CR39
  article-title: A fetally expressed immunoglobulin VH1 gene belongs to a complex set of alleles
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI116468
– volume: 337
  start-page: 1343
  year: 2012
  end-page: 1348
  ident: CR3
  article-title: Highly conserved protective epitopes on influenza B viruses
  publication-title: Science
  doi: 10.1126/science.1222908
– volume: 30
  start-page: 429
  year: 2012
  end-page: 457
  ident: CR23
  article-title: Germinal centers
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev-immunol-020711-075032
– volume: 97
  start-page: 2074
  year: 1996
  end-page: 2080
  ident: CR13
  article-title: Expression of the immunoglobulin VH gene 51p1 is proportional to its germline gene copy number
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI118644
– volume: 331
  start-page: 1203
  year: 2011
  end-page: 1207
  ident: CR25
  article-title: Different B cell populations mediate early and late memory during an endogenous immune response
  publication-title: Science
  doi: 10.1126/science.1201730
– volume: 38
  start-page: W695
  year: 2010
  end-page: W699
  ident: CR34
  article-title: A new bioinformatics analysis tools framework at EMBL-EBI
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkq313
– volume: 496
  start-page: 469
  year: 2013
  ident: BFnature13764_CR12
  publication-title: Nature
  doi: 10.1038/nature12053
– volume: 187
  start-page: 4229
  year: 2011
  ident: BFnature13764_CR21
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1000928
– volume: 354
  start-page: 389
  year: 1991
  ident: BFnature13764_CR10
  publication-title: Nature
  doi: 10.1038/354389a0
– volume: 10
  start-page: 1292
  year: 2009
  ident: BFnature13764_CR24
  publication-title: Nature Immunol.
  doi: 10.1038/ni.1814
– volume: 38
  start-page: W695
  year: 2010
  ident: BFnature13764_CR34
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkq313
– volume: 1
  start-page: 105
  year: 2007
  ident: BFnature13764_CR29
  publication-title: Influenza Other Respi. Viruses
  doi: 10.1111/j.1750-2659.2007.00016.x
– volume: 8
  start-page: 751
  year: 1998
  ident: BFnature13764_CR19
  publication-title: Immunity
  doi: 10.1016/S1074-7613(00)80580-4
– volume: 25
  start-page: 683
  year: 2013
  ident: BFnature13764_CR26
  publication-title: Int. Immunol.
  doi: 10.1093/intimm/dxt030
– volume: 337
  start-page: 1343
  year: 2012
  ident: BFnature13764_CR3
  publication-title: Science
  doi: 10.1126/science.1222908
– volume: 28
  start-page: 790
  year: 2010
  ident: BFnature13764_CR33
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.10.066
– volume: 306
  start-page: 18
  year: 2003
  ident: BFnature13764_CR28
  publication-title: Virology
  doi: 10.1016/S0042-6822(02)00035-1
– volume: 41
  start-page: W34
  year: 2013
  ident: BFnature13764_CR36
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkt382
– volume: 120
  start-page: 1663
  year: 2010
  ident: BFnature13764_CR7
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI41902
– volume: 324
  start-page: 246
  year: 2009
  ident: BFnature13764_CR2
  publication-title: Science
  doi: 10.1126/science.1171491
– volume: 333
  start-page: 850
  year: 2011
  ident: BFnature13764_CR4
  publication-title: Science
  doi: 10.1126/science.1205669
– volume: 20
  start-page: 867
  year: 2013
  ident: BFnature13764_CR15
  publication-title: Clin. Vaccine Immunol.
  doi: 10.1128/CVI.00735-12
– volume: 10
  start-page: e1004103
  year: 2014
  ident: BFnature13764_CR16
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1004103
– volume: 92
  start-page: 1254
  year: 1995
  ident: BFnature13764_CR20
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.92.5.1254
– volume: 329
  start-page: 112
  year: 2008
  ident: BFnature13764_CR32
  publication-title: J. Immunol. Methods
  doi: 10.1016/j.jim.2007.09.017
– volume: 13
  start-page: 693
  year: 2013
  ident: BFnature13764_CR22
  publication-title: Nature Rev. Immunol.
  doi: 10.1038/nri3516
– volume: 110
  start-page: 4261
  year: 2013
  ident: BFnature13764_CR8
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1301810110
– volume: 97
  start-page: 2074
  year: 1996
  ident: BFnature13764_CR13
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI118644
– volume: 6
  start-page: e22365
  year: 2011
  ident: BFnature13764_CR38
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0022365
– volume: 153
  start-page: 126
  year: 2013
  ident: BFnature13764_CR17
  publication-title: Cell
  doi: 10.1016/j.cell.2013.03.018
– volume: 501
  start-page: 439
  year: 2013
  ident: BFnature13764_CR27
  publication-title: Nature
  doi: 10.1038/nature12442
– volume: 3
  start-page: e3942
  year: 2008
  ident: BFnature13764_CR5
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0003942
– volume: 208
  start-page: 181
  year: 2011
  ident: BFnature13764_CR6
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20101352
– volume: 91
  start-page: 2358
  year: 1993
  ident: BFnature13764_CR39
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI116468
– volume: 110
  start-page: 264
  year: 2013
  ident: BFnature13764_CR18
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1218256109
– volume: 81
  start-page: 3180
  year: 1984
  ident: BFnature13764_CR11
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.81.10.3180
– volume: 41
  start-page: 401
  year: 2002
  ident: BFnature13764_CR14
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/41.4.401
– volume: 36
  start-page: W503
  year: 2008
  ident: BFnature13764_CR37
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkn316
– volume: 331
  start-page: 1203
  year: 2011
  ident: BFnature13764_CR25
  publication-title: Science
  doi: 10.1126/science.1201730
– volume: 10
  start-page: 871
  year: 2004
  ident: BFnature13764_CR31
  publication-title: Nature Med.
  doi: 10.1038/nm1080
– volume: 27
  start-page: 2335
  year: 2013
  ident: BFnature13764_CR30
  publication-title: AIDS
  doi: 10.1097/01.aids.0000432474.76873.5f
– volume: 45
  start-page: 3832
  year: 2008
  ident: BFnature13764_CR35
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2008.05.022
– volume: 16
  start-page: 265
  year: 2009
  ident: BFnature13764_CR1
  publication-title: Nature Struct. Mol. Biol.
  doi: 10.1038/nsmb.1566
– volume: 30
  start-page: 429
  year: 2012
  ident: BFnature13764_CR23
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev-immunol-020711-075032
– volume: 489
  start-page: 566
  year: 2012
  ident: BFnature13764_CR9
  publication-title: Nature
  doi: 10.1038/nature11371
– reference: 11961170 - Rheumatology (Oxford). 2002 Apr;41(4):401-10
– reference: 23440204 - Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4261-6
– reference: 23175789 - Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):264-9
– reference: 8621797 - J Clin Invest. 1996 May 1;97(9):2074-80
– reference: 23671333 - Nucleic Acids Res. 2013 Jul;41(Web Server issue):W34-40
– reference: 23552890 - Nature. 2013 Apr 25;496(7446):469-76
– reference: 23576673 - Clin Vaccine Immunol. 2013 Jun;20(6):867-76
– reference: 21930965 - J Immunol. 2011 Oct 15;187(8):4229-35
– reference: 21220454 - J Exp Med. 2011 Jan 17;208(1):181-93
– reference: 23969737 - Nat Rev Immunol. 2013 Sep;13(9):693-701
– reference: 21798894 - Science. 2011 Aug 12;333(6044):850-6
– reference: 6203114 - Proc Natl Acad Sci U S A. 1984 May;81(10):3180-4
– reference: 19855380 - Nat Immunol. 2009 Dec;10(12):1292-9
– reference: 21829618 - PLoS One. 2011;6(8):e22365
– reference: 19453415 - Influenza Other Respir Viruses. 2007 May;1(3):105-12
– reference: 20439314 - Nucleic Acids Res. 2010 Jul;38(Web Server issue):W695-9
– reference: 18503082 - Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W503-8
– reference: 23955151 - Nature. 2013 Sep 19;501(7467):439-43
– reference: 24021876 - Int Immunol. 2013 Dec;25(12):683-95
– reference: 21310965 - Science. 2011 Mar 4;331(6021):1203-7
– reference: 19887135 - Vaccine. 2010 Jan 8;28(3):790-7
– reference: 22878502 - Science. 2012 Sep 14;337(6100):1343-8
– reference: 9655489 - Immunity. 1998 Jun;8(6):751-9
– reference: 17996249 - J Immunol Methods. 2008 Jan 1;329(1-2):112-24
– reference: 18614234 - Mol Immunol. 2008 Aug;45(14):3832-9
– reference: 19234466 - Nat Struct Mol Biol. 2009 Mar;16(3):265-73
– reference: 12620793 - Virology. 2003 Feb 1;306(1):18-24
– reference: 22932267 - Nature. 2012 Sep 27;489(7417):566-70
– reference: 19079604 - PLoS One. 2008;3(12):e3942
– reference: 19251591 - Science. 2009 Apr 10;324(5924):246-51
– reference: 23540694 - Cell. 2013 Mar 28;153(1):126-38
– reference: 7877964 - Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1254-6
– reference: 23921607 - AIDS. 2013 Sep 24;27(15):2335-44
– reference: 8099917 - J Clin Invest. 1993 Jun;91(6):2358-67
– reference: 1956400 - Nature. 1991 Dec 5;354(6352):389-92
– reference: 20389023 - J Clin Invest. 2010 May;120(5):1663-73
– reference: 24788925 - PLoS Pathog. 2014 May 01;10(5):e1004103
– reference: 22224772 - Annu Rev Immunol. 2012;30:429-57
– reference: 15247913 - Nat Med. 2004 Aug;10(8):871-5
SSID ssj0005174
Score 2.5766258
Snippet The main pathway of somatic mutations leading to the generation of high affinity broadly neutralizing antibodies against the influenza haemagglutinin stem is...
The neutralizing antibody response to influenza virus is dominated by antibodies that bind to the globular head of haemagglutinin, which undergoes a continuous...
SourceID proquest
gale
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 418
SubjectTerms 13/56
631/250/2152/2040
Adult
Amino Acid Sequence
Antibodies
Antibodies, Neutralizing - genetics
Antigens
Cells, Cultured
Cloning
Complementarity Determining Regions - chemistry
Complementarity Determining Regions - genetics
Female
Gene mutations
Genetic aspects
Health aspects
Hemagglutinin Glycoproteins, Influenza Virus - immunology
Humanities and Social Sciences
Humans
Immunoglobulin Heavy Chains - genetics
Influenza
Influenza research
Influenza, Human - immunology
Influenza, Human - virology
letter
Male
Middle Aged
Models, Molecular
multidisciplinary
Mutation
Mutation - genetics
Orthomyxoviridae - immunology
Orthomyxoviridae - metabolism
Polymorphism, Genetic
Protein binding
Protein Binding - genetics
Protein Structure, Tertiary
Rodents
Science
Viral antibodies
Viruses
Young Adult
Title Rapid development of broadly influenza neutralizing antibodies through redundant mutations
URI https://link.springer.com/article/10.1038/nature13764
https://www.ncbi.nlm.nih.gov/pubmed/25296253
https://www.proquest.com/docview/1640677691
https://www.proquest.com/docview/1639498203
Volume 516
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED-xTUi8IDa-wkZl0PiUotmJ7TpPaEwrg4cJFSZVvES2Y0-VRtI17QP767ETt0vKxEte7mJHZ_t88f38O4BDLIUhwohYZtjElCkdqzTTMbFcY-XiA6YblO85P7ug3yZsEg7c6gCrXPnExlEXlfZn5EcurPdkZzwjn2bXsa8a5bOroYTGFuwQ54M9d7446UA8NliYw_08nIqjljaTuOVFezvSpl_ubEwbmdJmAxo9gochckTH7VDvwj1T7sH9BsGp6z3YDau0Ru8DlfSHx_BrLGfTAhW3yCBUWaTmlSyu_qBpW6DkRqLSLJsTjxvXM3K2nqrKowtRqOKD5sZfNnMC9HvZ5u7rJ3AxOv15chaHagqxZoIvYkmIsaxQ1v2hsYTywhJqCpV4oKfQqbZa8EwryQWzWie8wFi6vwmaGuNMaWX6FLbLqjTPARVCuMAo8SnZIcWKKxfjYINTjTW2LGERfFxZNNeBatxXvLjKm5R3KvKO-SM4XCvPWoaNu9Ve-6HJPWdF6UExl3JZ1_nXH-P8mPIm_UlJBO-Ckq1ch1qGOwbusz3NVU9zv6epZ9PrvCN925NetuN2VzMHPUW3NnVfvJpIefANdX47kyN4tRb7Nz3erTTV0uukGc1cdJZG8KydgGvjJD5VnjAnebOakZ3G_7Xci_9_xD48cEFgQ15JxAFsL-ZL89IFWgs1gK3hZDho1pR_jr4MYOfz6fn38V_86ynf
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9wwEB5Rqqq9VIW-UmjrVtAHUoQTO8E5VBWiRbuFcqAgoV6C7ThoJZosm40q-FH9jR3nsSRb1BvnmdjReDyeZD5_A7BGpTCeMMKVETUuD5R2FYu066Whpgrzg0BXKN-DcHDMv50EJwvwp70LY2GVbUysAnWSa_uPfBPTekt2Fkbe5_GFa7tG2epq20Kjdos9c_kbP9mKT8MvuL7rvr_79Whn4DZdBVwdiHDqSs8zaZCoFL9UAp-HSepxkyjfAh6FZjrVIoy0kqEIUq39MKFUYlbNmTEYPlLJcNw7cJcztmW5-sVOB1Iyx_rc3AekTGzWNJ0ebmfeOwHnz4HOQThXma0OvN1H8LDJVMl27VpLsGCyZbhXIUZ1sQxLTVQoyIeGuvrjY_h5KMejhCTXSCSSp0RNcpmcX5JR3RDlSpLMlNUfliucmeDajlRu0Yyk6RpEJsZebkMB-VXWWIHiCRzfip2fwmKWZ-Y5kEQITMR8WwLe4lSFCnMqaijTVNM08AMHNlqLxrqhNrcdNs7jqsTORNwxvwNrM-Vxzehxs9pbuzSx5cjILAjnTJZFEQ9_HMbbPKzKrdxz4H2jlOY4oZbNnQZ8bUur1dNc6Wnq8egi7kjf9aRn9brdNMxqTxFjge6LW0eKm1hUxNc7x4E3M7F90uLrMpOXVodFPMJskDnwrHbAmXF8W5r3A5Sstx7ZGfxfy734_0u8hvuDo-_78f7wYG8FHmACWhFnemIVFqeT0rzEJG-qXlU7i8DpbW_lvxF4ZCQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NIRAviI2vsAEGbXxJUZ3POg8ITYxqZWhCg0kVL8F27KnSSLqmEdr-NP46zonTNmXibc93saPzfSX38x3ADuVMeUwxlydUuWEkpCuCRLqejiUVmB9Eskb5HsUHJ-HnUTRagz_tXRgDq2x9Yu2os0Kaf-Q9TOtNs7M48XrawiK-7g8-TM5dM0HKVFrbcRqNihyqi9_4-Va-H-7jWe_6_uDT948Hrp0w4MqIxTOXe57SUSY0frVEfhhn2gtVJnwDfmQykFqyOJGCxyzSUvpxRinHDDsMlEJXonmA696Am_0AwybaUn_UX8BLVjpA27uBNGC9pmWnh6YddqLhakxYCoorVdo6-A3uwV2btZK9Rs02YE3lm3CrRo_KchM2rIcoyRvbxvrtffhxzCfjjGQLVBIpNBHTgmdnF2TcDEe55CRXVf235RJ3JnjOY1EYZCOxE4TIVJmLbkggv6oGN1A-gJNrkfNDWM-LXD0GkjGGSZlvysH9kIpYYH5FFQ0klVRHfuTAu1aiqbRtzs20jbO0LrcHLF0SvwM7c-ZJ093jaraX5mhS0y8jN5p3yquyTIffjtO9MK5Lr6HnwGvLpAvcUHJ7vwFf27TY6nBudTjlZHyeLlFfdainzbldtcx2hxH9guySW0VKrV8q04UVOfBiTjZPGqxdrorK8ARJmGBmGDjwqFHAuXB8U6b3I6Tsthq5tPi_knvy_5d4DrfRiNMvw6PDLbiDuWjdQ9Nj27A-m1bqKeZ7M_GsNiwCP6_bkv8CAtBohg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rapid+development+of+broadly+influenza+neutralizing+antibodies+through+redundant+mutations&rft.jtitle=Nature+%28London%29&rft.au=Pappas%2C+Leontios&rft.au=Foglierini%2C+Mathilde&rft.au=Piccoli%2C+Luca&rft.au=Kallewaard%2C+Nicole+L.&rft.date=2014-12-18&rft.pub=Nature+Publishing+Group+UK&rft.issn=0028-0836&rft.eissn=1476-4687&rft.volume=516&rft.issue=7531&rft.spage=418&rft.epage=422&rft_id=info:doi/10.1038%2Fnature13764&rft.externalDocID=10_1038_nature13764
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-0836&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-0836&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-0836&client=summon